SEC Form 4 · accession 0000899243-15-004434
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce L. Claflin
Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitF1,F2 | — | Sep 1, 2015 | A | 503 | A | — | — | Common Stock | 503 | 503 | D |
| Non-Qualified Stock Option (Right to Buy)F1,F3 | $70.54 | Sep 1, 2015 | A | 5,629 | A | — | Aug 31, 2025 | Common Stock | 5,629 | 5,629 | D |
Explanation of responses
- F1This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on 07/14/2015 until the Company's 2016 annual meeting of stockholders.
- F2Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest fully on 05/04/2016 and are payable as common stock one year following the Director's resignation from the Board of Directors.
- F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests fully on 05/04/2016.